Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial

Hdl Handle:
http://hdl.handle.net/10144/322813
Title:
Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial
Authors:
Laureillard, D; Marcy, O; Madec, Y; Chea, S; Chan, S; Borand, L; Fernandez, M; Prak, N; Kim, C; Dim, B; Nerrienet, E; Sok, T; Delfraissy, J-F; Goldfeld, A E; Blanc, F-X
Journal:
AIDS
Abstract:
To analyze cases of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) in the CAMbodian Early versus Late Introduction of Antiretrovirals (CAMELIA) randomized trial designed to compare early (2 weeks) versus late (8 weeks) antiretroviral therapy (ART) initiation after tuberculosis treatment onset in Cambodia (NCT00226434).
Affiliation:
a) French National Agency for Research on AIDS and Viral Hepatitis (ANRS), Ho Chi Minh City, Vietnam b) Institut Pasteur du Cambodge, Phnom Penh, Cambodia c) Cambodian Health Committee, Phnom Penh, Cambodia d) Institut Pasteur, Paris, France e) Calmette Hospital, Phnom Penh, Cambodia f) Khmer Soviet Friendship Hospital, Phnom Penh, Cambodia g) Donkeo Provincial Hospital, Takeo, Cambodia h) Médecins Sans Frontières, Phnom Penh, Cambodia i) Siem Reap Referral Hospital, Siem Reap, Cambodia j) Assistance Publique - Hôpitaux de Paris, Hôpital Bicêtre, Hôpitaux Universitaires Paris Sud, Le Kremlin-Bicêtre, France k) Program in Cellular and Molecular Medicine, Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publisher:
Lippincott Williams & Wilkins
Issue Date:
23-Oct-2013
URI:
http://hdl.handle.net/10144/322813
DOI:
10.1097/01.aids.0000432456.14099.c7
PubMed ID:
24096631
Language:
en
ISSN:
1473-5571
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorLaureillard, Den_GB
dc.contributor.authorMarcy, Oen_GB
dc.contributor.authorMadec, Yen_GB
dc.contributor.authorChea, Sen_GB
dc.contributor.authorChan, Sen_GB
dc.contributor.authorBorand, Len_GB
dc.contributor.authorFernandez, Men_GB
dc.contributor.authorPrak, Nen_GB
dc.contributor.authorKim, Cen_GB
dc.contributor.authorDim, Ben_GB
dc.contributor.authorNerrienet, Een_GB
dc.contributor.authorSok, Ten_GB
dc.contributor.authorDelfraissy, J-Fen_GB
dc.contributor.authorGoldfeld, A Een_GB
dc.contributor.authorBlanc, F-Xen_GB
dc.date.accessioned2014-07-10T16:40:03Z-
dc.date.available2014-07-10T16:40:03Z-
dc.date.issued2013-10-23-
dc.identifier.citationParadoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial. 2013, 27 (16):2577-86 AIDSen_GB
dc.identifier.issn1473-5571-
dc.identifier.pmid24096631-
dc.identifier.doi10.1097/01.aids.0000432456.14099.c7-
dc.identifier.urihttp://hdl.handle.net/10144/322813-
dc.description.abstractTo analyze cases of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) in the CAMbodian Early versus Late Introduction of Antiretrovirals (CAMELIA) randomized trial designed to compare early (2 weeks) versus late (8 weeks) antiretroviral therapy (ART) initiation after tuberculosis treatment onset in Cambodia (NCT00226434).en_GB
dc.language.isoenen
dc.publisherLippincott Williams & Wilkinsen_GB
dc.subjectHIV/AIDSen_GB
dc.subjectTuberculosisen_GB
dc.titleParadoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trialen
dc.contributor.departmenta) French National Agency for Research on AIDS and Viral Hepatitis (ANRS), Ho Chi Minh City, Vietnam b) Institut Pasteur du Cambodge, Phnom Penh, Cambodia c) Cambodian Health Committee, Phnom Penh, Cambodia d) Institut Pasteur, Paris, France e) Calmette Hospital, Phnom Penh, Cambodia f) Khmer Soviet Friendship Hospital, Phnom Penh, Cambodia g) Donkeo Provincial Hospital, Takeo, Cambodia h) Médecins Sans Frontières, Phnom Penh, Cambodia i) Siem Reap Referral Hospital, Siem Reap, Cambodia j) Assistance Publique - Hôpitaux de Paris, Hôpital Bicêtre, Hôpitaux Universitaires Paris Sud, Le Kremlin-Bicêtre, France k) Program in Cellular and Molecular Medicine, Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.en_GB
dc.identifier.journalAIDSen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.